Kashiv BioSciences Acquired by Amneal Pharmaceuticals | Healthcare M&A Deal

Amneal Pharmaceuticals has acquired Kashiv BioSciences, a pharmacy business in New Jersey, for up to $1.1 billion. Kashiv BioSciences acquisition brings pharmaceutical development and commercialization capabilities that support Amneal Pharmaceuticals acquisitions in the healthcare sector. The strategic acquisition expands Amneal’s pipeline and strengthens its position in pharmacy-focused healthcare M&A. The merger acquisition is announced and structured as a strategic acquisition by a corporate buyer, with deal value reported at up to $1.1 billion.